Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge

2

By Deena Beasley Oct 29 (Reuters) – Bristol ​Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)